Nanjing King-Friend Biochemical Pharmaceutical (603707.SHG) Q4 2025 Earnings

24OctConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
0.05
0.11
0.18
0.24

Details

Expected EPS
0.24000385752000003
Actual EPS
0.09000144656999999
Surprise EPS
-0.15
Surprise Percent
+62.5%

Description

Nanjing King-Friend Biochemical Pharmaceutical (603707.SHG) has reported earnings of 0.09000144656999999 per share for Q4 2025.

0 Comments

Share your thoughts